Understanding Non Invasive Prenatal Testing (NIPT) What is NIPT? The Non Invasive Prenatal Testing (NIPT) is a revolutionary screening tool that allows parents to assess the risk of certain genetic...
Results in 3-5 working days
Understanding Non Invasive Prenatal Testing (NIPT) - PrenatalSAFE 5 What is Non Invasive Prenatal Testing (NIPT)? Non Invasive Prenatal Testing (NIPT) is a revolutionary method that provides expectant parents with...
Results in 3-5 working days
Understanding Non Invasive Prenatal Testing (NIPT) Non Invasive Prenatal Testing (NIPT) - PrenatalSAFE Karyo is a groundbreaking method used to assess the risk of certain genetic disorders in a fetus,...
Results in 5-7 working days
Understanding Non Invasive Prenatal Testing (NIPT) - PrenatalSAFE Karyo Plus What is NIPT? Non Invasive Prenatal Testing (NIPT) - PrenatalSAFE Karyo Plus is a groundbreaking method that allows expectant parents...
Results in 10-12 working days
Understanding Non Invasive Prenatal Testing (NIPT) - PrenatalSAFE Complete Plus What is Non Invasive Prenatal Testing? Non Invasive Prenatal Testing (NIPT) - PrenatalSAFE Complete Plus is a revolutionary method designed...
Free post-test genetic counselling for any positive result
Understanding the Early Baby Gender Blood Test What is an Early Baby Gender Blood Test? The Early Baby Gender Blood Test is a safe and effective way to determine your...
Same day results*
Enquire via the form and a member of our team will get back to you, they are more than happy to help answer your questions and talk through the best option for you.
Contact us if you aren’t sure, we’d be happy to help!
NIPT (Non-Invasive Prenatal Testing) blood tests are safe and non-Invasive screening tests that use DNA found in your blood to detect chromosomal anomalies in your baby, and their gender, from the earliest weeks of your pregnancy.
MOST COMMON DISORDERS
Our genetic health tests are called NIPT tests, or Non-Invasive Prenatal Tests. An NIPT is a blood test taken from the mother during pregnancy, using state of the art DNA technology to check whether the baby has high risks of certain chromosomal health conditions.
During pregnancy the placenta sheds cell free DNA (cfDNA) into the mother’s bloodstream. This means that the mother’s blood continues a mixture of your own DNA, and that of your baby’s placenta. By extracting and evaluating the cfDNA in your blood, we can identify the risk to your baby of a range of health conditions and diseases.
Suitable for women of all ages, of at least 10 weeks of gestation (at the time of their blood draw appointment), who have had their pregnancy type (single or twin) previously confirmed by an ultrasound scan. The pregnancy can be naturally conceived or through IVF.
NIPT tests detect foetal abnormalities at a very early stage of 10 weeks pregancy. Our advanced NIPT tests offer more in-depth information than what is currently available on the NHS.
The information allows you to make an informed decision about health concerns you want to know about.
Our NIPT tests detect foetal abnormalities at a very early stage, from week 10 of pregnancy, with a high degree of accuracy and a low false-positive rate.
Only the equivalent of the PrenatalSAFE 3 test is available on the NHS, and even then only for at-risk mothers.
Our range of tests is available to all, and offers a comprehensive choice so you can make an informed decision about the health concerns you want to know about.
Ongoing malignant tumour conditions
Previous bone marrow or organ transplant, or stem cell therapy
Recent blood transfusion (within the last 4 months)
Mother affected by trisomy 21 or certain balanced translocation or mosaicism of T21, T18 or T13
Immunotherapy (other than those required for IVF treatment (e.g. intravenous immunoglobulin – IVIg)
Triplets or higher-order pregnancies
Book online, receive your kit and take to your local Goodbody clinic.
Send your sample in the post to be analysed at an accredited laboratory.
Get your comprehensive detailed results report from the laboratory, with guidance from our support team.